MeSH tree: D02.886.590.700
The cholesterol medication alirocumab, a PCSK9 inhibitor, combined with a statin appeared to reduce LDL cholesterol levels by more than 50% among patients after a heart transplant, according to a late-breaking science presentation ...
Nov 10, 2025
0
18
The first time Joey Carlsen Martinez came to Memorial Sloan Kettering Cancer Center (MSK), he was in terrible shape. He had a rare blood cancer called Erdheim-Chester disease, and his symptoms included crushing fatigue, severe ...
Oct 23, 2025
0
19
Mutations in a gene known as CPD play a crucial role in a rare form of congenital hearing loss, an international team of researchers has discovered.
Oct 15, 2025
0
29
A new study published in the European Journal of Heart Failure reveals that the speed of lymph flow in the legs may determine how well patients respond to diuretics, a key therapy for acute heart failure (AHF).
Oct 8, 2025
0
19
Methotrexate, a common medication used to treat rheumatoid arthritis, has a newly recognized useful secondary effect of lowering blood pressure and potentially reduces the risk of heart disease in people with this condition.
Sep 3, 2025
0
26
More patients with hypercholesterolemia at high/very high risk of cardiovascular (CV) events achieved low-density lipoprotein cholesterol (LDL-C) goals with inclisiran compared with placebo, when given on top of individually ...
Sep 1, 2025
0
14
Researchers at Kyoto University have discovered that "immune hubs" in the kidney create a unique metabolic environment that could be targeted for new treatments. These clusters of immune cells, called tertiary lymphoid structures ...
Aug 26, 2025
0
17
There is broad consensus that the overall body of evidence shows lowering LDL (low-density lipoprotein) cholesterol provides both statistically significant and clinically meaningful benefits in treating and preventing cardiovascular ...
Jul 28, 2025
0
66
In a wholly new approach to cancer treatment, Northwestern University biomedical engineers have doubled the effectiveness of chemotherapy in animal experiments.
Jul 23, 2025
0
186
The U.S. Food and Drug Administration has approved George Medicines' Widaplik (telmisartan, amlodipine, and indapamide) for the treatment of hypertension in adults.
Jun 12, 2025
0
26
